The NMDA receptor is a major mediator of the neuronal plasticity that occurs in the spinal cord dorsal horn (SCDH) and its activation results in the facilitation of injury-induced pain and to the development of opioid tolerance. Following CFA-induced inflammation, a spatial functional knockout (KO) of the NMDA receptor (NR1) that we have developed, prevents evoked allodynia. This protective effect is lost with time suggesting the onset of a transcriptionally mediated NMDA receptor-independent pain process. In this revised application we will use the spatial NR1 KO mouse to identify the contribution of selected spinal cord dorsal horn (SCDH) neuronal and glial proteins (dynorphin, NK-1 receptors, COX-2, ERKI/2, p38 MAPK and proinflammatory cytokines) to activated pain states in the presence and absence of NMDA receptors (Aim 1). The expression levels of these proteins will be measured (immunocytochemistry, Western blot, in situ hybridization, RT PCR and ribonuclease protection assays) in SCDH after inflammation or nerve injury to determine which proteins are upregulated and whether this increased expression is NMDA receptor dependent. Inhibitors of these proteins will be evaluated for their efficacy in reducing activated pain states (evoked allodynia) in these animals. The NR1 KO mouse will also be used to define the contribution of SCDH NMDA receptors to systemic and intrathecal morphine tolerance. Recombinant adenoassociated viral (rAAV) vectors will be used to deliver therapeutic molecules in the form of RNAi, antisense or antiinflammatory cytokines in a spatially directed manner to the SCDH so as to validate the in vivo utility of targeting selected pain activated proteins (Aim 2). A strategy is presented to design and test shRNAs that will be processed in vivo into siRNAs that will cleave our proof of principle target, NR1 mRNA resulting in a spatial knockdown of NR1. A complementary approach will use a rAAV vector to spatially localize the expression of anti-inflammatory cytokines in SCDH. In vitro and in vivo studies will be used to evaluate the properties of these vectors. The proposed research will improve our understanding of the contribution of the NMDA receptor to the pain activated protein cascade, identify therapeutic targets and will provide new gene expression based therapeutic approaches for the management of pain and opioid tolerance. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA001457-32
Application #
7106621
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Lin, Geraline
Project Start
1976-05-01
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
32
Fiscal Year
2006
Total Cost
$369,116
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Xu, Jin; Xu, Ming; Brown, Taylor et al. (2013) Stabilization of the ?-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. J Biol Chem 288:21211-27
Schierberl, Kathryn; Hao, Jin; Tropea, Thomas F et al. (2011) Cav1.2 L-type Ca²? channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. J Neurosci 31:13562-75
Hunter, Deirtra A; Barr, Gordon A; Amador, Nicole et al. (2011) Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation. Synapse 65:643-51
Hunter, Deirtra A; Barr, Gordon A; Shivers, Kai-Yvonne et al. (2011) Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia. Brain Res 1382:181-8
Gregus, Ann M; Tropea, Thomas F; Wang, Yanran et al. (2010) Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference. Neurosci Lett 468:186-9
Weyerbacher, Amanda R; Xu, Qinghao; Tamasdan, Cristina et al. (2010) N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain 148:237-46
Gregus, A M; Inra, C N; Giordano 3rd, T P et al. (2010) Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5. Neuroscience 169:475-87
Bogulavsky, Johanna J; Gregus, Ann M; Kim, Paul T-H et al. (2009) Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance. J Pharmacol Exp Ther 328:579-87
Garraway, Sandra M; Xu, Qinghao; Inturrisi, Charles E (2009) siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. J Pain 10:380-90
Klein, Gad; Rossi, Grace C; Waxman, Amanda R et al. (2009) The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence. Neurosci Lett 457:115-9

Showing the most recent 10 out of 52 publications